MicroRNAs in mesenteric lymph and plasma during acute pancreatitis

Annals of Surgery

Volumn 260, Issue 2, 2014, Pages 341-347

  Blenkiron, Cherie ^a   Askelund, Kathryn J ^a   Shanbhag, Satyanarayan T ^a   Chakraborty, Mandira ^a   Petrov, Maxim S ^a   Delahunt, Brett ^b   Windsor, John A ^a,c   Phillips, Anthony R ^a,c,d  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c MAURICE WILKINS CENTRE FOR MOLECULAR BIODISCOVERY   (New Zealand)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Biofluid; Blood; Circulation; Lymphatic; Pancreas

Indexed keywords

5' NUCLEOTIDASE; AMYLASE; CD39 ANTIGEN; CYTOKINE RECEPTOR; HEPARAN SULFATE; INTERLEUKIN 13 RECEPTOR ALPHA1; MICRORNA; MICRORNA 122; MICRORNA 138; MICRORNA 148A; MICRORNA 20A; MICRORNA 210; MICRORNA 214; MICRORNA 216A; MICRORNA 217; MICRORNA 222; MICRORNA 24; MICRORNA 27A; MICRORNA 324 3P; MICRORNA 342 3P; MICRORNA 351; MICRORNA 375; MICRORNA 425; MICRORNA 429; MICRORNA 451; MICRORNA 497; MITOGEN ACTIVATED PROTEIN KINASE; TAUROCHOLIC ACID; TRANSFORMING GROWTH FACTOR BETA; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ABDOMINAL PAIN; ABDOMINAL RADIOGRAPHY; ACTIN FILAMENT; ACUTE PANCREATITIS; AMEBIASIS; AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CHROMOSOME 4; COLORECTAL CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; HEMOLYMPHATIC SYSTEM; HUMAN; LYMPH; MALE; MEAN ARTERIAL PRESSURE; MESENTERY; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN DEGRADATION; PROTEIN PROCESSING; PURINE METABOLISM; PYRIMIDINE METABOLISM; QUANTITATIVE ANALYSIS; RAT; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHAM PROCEDURE; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; WNT SIGNALING PATHWAY; ANIMAL; ANTIBODY SPECIFICITY; BLOOD; DISEASE MODEL; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; PANCREATITIS; REPRODUCIBILITY; WISTAR RAT;

ANIMALS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; HUMANS; LYMPH; MALE; MESENTERY; MICRORNAS; ORGAN SPECIFICITY; PANCREATITIS; PLASMA; RATS; RATS, WISTAR; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84905577526     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000447     Document Type: Article

References (45)

1. Windsor JA. Search for prognostic markers for acute pancreatitis. Lancet. 2000;355:1924-1925.
2. Windsor JA. Assessment of the severity of acute pancreatitis: no room for complacency. Pancreatology. 2008;8:105-109.
3. Whitcomb DC. Clinical practice. Acute pancreatitis. N Engl J Med. 2006;354:2142-2150.
4. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75:843-854.
5. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215-233.
6. EstellerM. Non-coding RNAs in human disease. Nat Rev Genet. 2011;12:861-874.
7. Weber JA, Baxter DH, Zhang S, et al. The microRNA spectrum in 12 body fluids. Clin Chem. 2010;56:1733-1741.
8. Valadi H, Ekstrom K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9:654-659.
9. Arroyo JD, Chevillet JR, Kroh EM, et al. Argonaute2 complexes carry a population of circulatingmicroRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A. 2011;108:5003-5008.
10. Wang K, Zhang S, Weber J, et al. Export of microRNAs and microRNAprotective protein by mammalian cells. Nucleic Acids Res. 2010;38:7248-7259.
11. Clement CC, Rotzschke O, Santambrogio L. The lymph as a pool of self-antigens. Trends Immunol. 2011;32:6-11.
12. Fanous MY, Phillips AJ, Windsor JA. Mesenteric lymph: the bridge to future management of critical illness. JOP. 2007;8:374-399.
13. Deitch EA. Gut-origin sepsis: evolution of a concept. Surgeon. 2012;10:350-356.
14. Mittal A, Middleditch M, Ruggiero K, et al. Changes in the mesenteric lymph proteome induced by hemorrhagic shock. Shock. 2010;34:140-149.
15. Mittal A, Phillips AR, Middleditch M, et al. The proteome ofmesenteric lymph during acute pancreatitis and implications for treatment. JOP. 2009;10:130-142.
16. Morishita K, Aiboshi J, Kobayashi T, et al. Lipidomics analysis of mesenteric lymph after trauma and hemorrhagic shock. J Trauma Acute Care Surg. 2012;72:1541-1547.
17. Heggermont WA, Heymans S. MicroRNAs are involved in end-organ damage during hypertension. Hypertension. 2012;60:1088-1093.
18. Aho HJ, Koskensalo SM, Nevalainen TJ. Experimental pancreatitis in the rat. Sodium taurocholate-induced acute haemorrhagic pancreatitis. Scand J Gastroenterol. 1980;15:411-416.
19. Schmidt J, Lewandrowski K, Fernandez-del Castillo C, et al. Histopathologic correlates of serum amylase activity in acute experimental pancreatitis. Dig Dis Sci. 1992;37:1426-1433.
20. Petrov MS, McIlroy K, Grayson L, et al. Early nasogastric tube feeding versus nil per os in mild to moderate acute pancreatitis: a randomized controlled trial. Clin Nutr. 2013;32:697-703.
21. Dellinger EP, Forsmark CE, Layer P, et al. Determinant-based classification of acute pancreatitis severity: an international multidisciplinary consultation. Ann Surg. 2012;256:875-880.
22. Petrov MS, Windsor JA. Classification of the severity of acute pancreatitis: how many categories make sense? Am J Gastroenterol. 2010;105:74-76.
23. Marshall JC, Cook DJ, Christou NV, et al. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med. 1995;23:1638-1652.
24. Kroh EM, Parkin RK, Mitchell PS, et al. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods. 2010;50:298-301.
25. Vlachos IS, Kostoulas N, Vergoulis T, et al. DIANA miRPath v. 2.0: investigating the combinatorial effect of microRNAs in pathways. Nucleic Acids Res. 2012;40:W498-W504.
26. Griffiths-Jones S. miRBase: the microRNA sequence database. Methods Mol Biol. 2006;342:129-138.
27. Shigehara K, Yokomuro S, Ishibashi O, et al. Real-time PCR-based analysis of the human bile microRNAome identifies miR-9 as a potential diagnostic biomarker for biliary tract cancer. PLoS One. 2011;6:e23584.
28. Kent OA, Chivukula RR, Mullendore M, et al. Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway. Genes Dev. 24:2754-2759.
29. Ugras S, Brill E, Jacobsen A, et al. Small RNA sequencing and functional characterization reveals microRNA-143 tumor suppressor activity in liposarcoma. Cancer Res. 2011;71:5659-5669.
30. Zeng L, Childs SJ. The smooth muscle microRNA miR-145 regulates gut epithelial development via a paracrine mechanism. Dev Biol. 2012;367:178-186.
31. Pekow JR, Dougherty U, Mustafi R, et al. miR-143 and miR-145 are downregulated in ulcerative colitis: putative regulators of inflammation and protooncogenes. Inflamm Bowel Dis. 2012;18:94-100.
32. Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008;105:10513-10518.
33. Semenov DV, Baryakin DN, Brenner EV, et al. Unbiased approach to profile the variety of small non-coding RNA of human blood plasma with massively parallel sequencing technology. Expert Opin Biol Ther. 2012;12(suppl 1):S43-S51.
34. Szafranska AE, Doleshal M, Edmunds HS, et al. Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues. Clin Chem. 2008;54:1716-1724.
35. Mittelbrunn M, Gutierrez-Vazquez C, Villarroya-Beltri C, et al. Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat Commun. 2011;2:282.
36. Mole DJ, McFerran NV, Collett G, et al. Tryptophan catabolites in mesenteric lymph may contribute to pancreatitis-associated organ failure. Br J Surg. 2008;95:855-867.
37. Rane SG, Lee JH, Lin HM. Transforming growth factor-beta pathway: role in pancreas development and pancreatic disease. Cytokine Growth Factor Rev. 2006;17:107-119.
38. Biczo G, Hegyi P, Dosa S, et al. The crucial role of early mitochondrial injury in L-lysine-induced acute pancreatitis. Antioxid Redox Signal. 2011;15:2669-2681.
39. Ansari D, Andersson E, Andersson B, et al. Chronic pancreatitis: potential future interventions. Scand J Gastroenterol. 2010;45:1022-1028.
40. Szafranska AE, Davison TS, John J, et al. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene. 2007;26:4442-4452.
41. Poy MN, Eliasson L, Krutzfeldt J, et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature. 2004;432:226-230.
42. Bolmeson C, Esguerra JL, Salehi A, et al. Differences in islet-enriched miRNAs in healthy and glucose intolerant human subjects. Biochem Biophys Res Commun. 2011;404:16-22.
43. Melkman-Zehavi T, Oren R, Kredo-Russo S, et al. miRNAs control insulin content in pancreatic beta-cells via downregulation of transcriptional repressors. EMBO J. 2011;30:835-845.
44. Malmstrom ML, Hansen MB, Andersen AM, et al. Cytokines and organ failure in acute pancreatitis: inflammatory response in acute pancreatitis. Pancreas. 2012;41:271-277.
45. Liu H, Li Y, Wang L, et al. Aggravation of acute pancreatitis by heparan sulfate in mice. Scand J Gastroenterol. 2009;44:626-632.